White House Budget Leans Into Drug Pricing, Obamacare Expansion

President Biden’s budget proposal focuses heavily on expanding access to health care and lowering the cost of prescription drugs.

In an effort to extend the life of Medicare’s hospital trust fund, the budget proposal would increase the number of drugs that can be negotiated, and allow those negotiations to begin sooner.

The plan builds off the Inflation Reduction Act (IRA), which granted Medicare the power to negotiate the prices of up to 20 drugs each year — though the drugs can only qualify after being on the market for at least nine years.

The IRA passed with only Democratic votes last year, and some in the GOP have already claimed they will try to repeal it.

Another IRA provision that would get a boost in the budget is the requirement that drug companies pay rebates to Medicare when they increase prices faster than inflation. Under the White House proposal, that requirement would extend to the commercial market as well.

The budget also seeks to extend the $35 insulin cap to the private sector. Under the IRA, Medicare beneficiaries won’t pay more than $35 out of pocket for insulin.

A proposal to cap the cost for all Americans was defeated by Senate Republicans.

The White House budget also includes proposals to expand ObamaCare programs.

It calls for permanently expanding enhanced subsidies for health plans on the exchanges, which currently expire at the end of 2025. The enhanced subsidies make insurance premiums free for most Americans with incomes just above the poverty line, and they lower the cost of premiums for Americans with higher incomes.

The budget also proposes “Medicaid-like” coverage for eligible people in states that haven’t expanded Medicaid coverage yet, paired with financial incentives to ensure states maintain their existing expansions.

Republicans began blasting elements of the budget before it was formally released, and are not likely to support the proposals.

The White House called the budget a “blueprint” to build on progress from the first two years of the administration. It claims that Republicans “have taken a very different approach” and want to add to the nation’s debt.


Source Link

Recommended Articles

AI in Healthcare: Calls for Stricter Standards Amid OpenAI Leadership Shuffle

Recent disruptions in OpenAI’s top brass have sparked intense dialogue within the healthcare sector, emphasizing the urgent need for robust standards governing the implementation of generative AI technologies. With Microsoft recruiting former OpenAI executives Sam Altman and Greg Brockman, concerns are growing that few corporations may soon dictate the trajectory of healthcare AI, potentially molding ...

Read More

2024 FSA, HSA, and HDHP Plan Limits

A health Flexible Spending Account (FSA) is an employer-sponsored benefit that allows eligible employees to save pre-tax dollars to pay for qualified medical expenses. Employees can elect a specific dollar amount, up to a certain limit, to set aside annually.

Read More

Proposals On PBMs And Medical Devices Advanced By House Subcommittee

The House Committee on Energy and Commerce health subcommittee pushed forward 21 proposals on Tuesday, some of which will restrict the power of pharmacy benefit managers (PBMs). Democrats supported many of the proposals put forward by Republicans, including legislation reining in PBMs that had support from 60 organizations representing patients, providers, pharmacists, small businesses and ...

Read More

CMS Tightening Network Adequacy Standards For Exchange Plans

Beginning in 2025, health plans sold in state-run insurance exchanges would be required to meet time and distance standards that are at least as adequate as mandated on federal marketplaces, according to a rule released by the Centers for Medicare & Medicaid Services (CMS) on Wednesday. Time and distance standards would be calculated at the ...

Read More